Carsten Mainitz
The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.
Most recently, he headed a Hamburg-based investment research company as a member of the board for 8 years.
He is particularly interested in international small and micro caps and empirical capital market research (behavioral finance).
Commented by Carsten Mainitz
Commented by Carsten Mainitz on July 1st, 2021 | 12:11 CEST
Pure Extraction, Ballard Power, SFC Energy - H2 mobility for commercial vehicles: These are the winners!
The advance of e-mobility associated with the energy transition and the need to decarbonize the economy does not stop at the commercial vehicle segment. However, the battery technology currently gaining acceptance in this sector has decisive disadvantages: it is expensive, has a heavy weight, and charging is time-consuming. For this reason, alternatives are feverishly being sought. Can hydrogen fill this gap? In contrast to suppliers like BYD, who focus primarily on battery mobility, the following companies concentrate fully on hydrogen technology. Who is in the running?
Read
Commented by Carsten Mainitz on June 30th, 2021 | 12:59 CEST
CureVac, Cardiol Therapeutics, MorphoSys - Here it is going powerfully upwards!
Biotech stocks offer investors not only an exciting but also a very profitable investment environment. But the sector is also attractive for traders due to its high volatility. CureVac took a beating recently as the efficacy of its Corona vaccine disappointed. The price of MorphoSys falls despite good news and positive analyst comments. The Canadian Cardiol Therapeutics could be on the verge of a revaluation. Where can the most significant gains be made in the short term?
Read
Commented by Carsten Mainitz on June 29th, 2021 | 12:37 CEST
Siemens Energy, QMines, AUTO1 Group - Watch out: invest in the best stock market newcomers!
IPO underpricing measures the difference between the price subscribers have to pay for new issues, i.e. the issue price and the prices then traded on the stock exchange. This phenomenon was first addressed in studies some 50 years ago. In sum, IPO underpricing exists worldwide. However, depending on the market phase, country and market capitalization size, this effect can look very different. It is, therefore, wrong to conclude that every IPO is a success. We separate the wheat from the chaff. Which stock is a clear buy?
Read
Commented by Carsten Mainitz on June 28th, 2021 | 14:42 CEST
BYD, EuroSports Global, Varta - Electric music is playing in Asia
Electromobility is considered the central building block of a sustainable and climate-friendly transportation system based on renewable energies. There are currently around 70 electric vehicle models from German manufacturers on the market. In 2020, the stock of passenger cars with electric drives in Germany comprised only 137,000 vehicles, according to the Federal Motor Transport Authority. The federal government wants to significantly boost the market with purchase incentives by the end of 2025, extensive investments in expanding the charging infrastructure and tax incentives. However, if you look at the global situation, it quickly becomes evident that Asia dominates the action. We introduce you to three stocks that offer great opportunities. Who has the best cards?
Read
Commented by Carsten Mainitz on June 25th, 2021 | 11:29 CEST
Commerzbank, Theta Gold Mines, Corestate Capital - Watch out: the hunt has begun!
The value and the price paid for a share on the stock exchange can be thought of in very different ways. If there is too big a discrepancy here, the hour strikes for wise investors. Undervaluation or overvaluation is always in the eye of the beholder. Time will tell whether it was a "value" buy or a "value trap." We pick up the trail of three exciting investments. Where are opportunities lurking, and where are the dangers?
Read
Commented by Carsten Mainitz on June 24th, 2021 | 11:10 CEST
About You, RYU Apparel, TUI - Short and simple: Cool returns!
Treat yourself. Now that the world is getting a little more normal and the sun is shining, the desire to travel is increasing. But a shopping spree or two can also inspire. And if you are feeling sporty, buying a stylish, innovative sports outfit kills two birds with one stone. We have brought along three exciting stocks. Who will win the race?
Read
Commented by Carsten Mainitz on June 23rd, 2021 | 11:28 CEST
Standard Lithium, Osino Resources, Ballard Power - These stocks are going through the roof
When German investors think of Canadian stocks, two topics usually come to mind: commodities and cannabis. Many companies from these two sectors are headquartered in one of the Canadian cities of Montreal, Vancouver or Toronto. The Canadian stock market accounts for 5% of the world's stock market capitalization, while the country holds only 0.5% of the world's population. But there are also interesting investments outside the two sectors mentioned. So who makes the race?
Read
Commented by Carsten Mainitz on June 22nd, 2021 | 12:36 CEST
MorphoSys, Defence Therapeutics, Formycon - Biotechnology shares with great potential
In the wake of the corona pandemic, companies such as BioNTech, Pfizer and Moderna demonstrated how quickly and safely vaccines can be developed and mass-produced using innovative biotechnological processes. Biotech stocks have risen in favor again, even outside Covid-19. However, some stocks lag behind the price targets forecast by experts, while others are slowly moving (again) in the right direction. We look at three stocks that offer excellent opportunities at the current price level.
Read
Commented by Carsten Mainitz on June 21st, 2021 | 14:19 CEST
Barrick Gold, NSJ Gold, First Majestic Silver- Buy and stay patient
In Gold we trust - is the name of a publication that has been published since 2007 and has become a benchmark for interested gold investors. The authors believe that gold and silver have an excellent chance to climb to higher prices at the end of the current year. For the end of the decade, the experts forecast at least a price of USD 4,800 per ounce of gold. Given such optimistic forecasts, we will look below at three shares that should benefit significantly from this.
Read
Commented by Carsten Mainitz on June 18th, 2021 | 15:10 CEST
MorphoSys, Biogen, Sierra Growth - What is next?
Pharmaceutical stocks are a bit like that: Giants like Johnson & Johnson or Novartis have an extensive product portfolio and can cushion failures of individual products quite well. It is often a matter of life and death for smaller, specialized companies with every development. Just yesterday, this could be observed in the CureVac share after its Corona vaccine candidate only achieved an efficacy of 47% in the clinical 2b/3 phase. Within a very short time, it disintegrated the stock price. Meanwhile, biotech pioneer Biogen surprised with an unjustified share price rally, which, however, could come to an abrupt end after a new setback. The situation is different for MorphoSys. Its planned acquisition of Constellation Pharmaceuticals initially weighed heavily on the share price, but it holds exciting potential. And the Canadian mining Company Sierra Growth is operating in a completely different environment; however, it has a top opportunity to offer in the current inflationary environment and should not go unmentioned.
Read